1. Home
  2. SRTA vs KMDA Comparison

SRTA vs KMDA Comparison

Compare SRTA & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRTA

Strata Critical Medical Inc.

HOLD

Current Price

$5.53

Market Cap

425.3M

Sector

N/A

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$8.48

Market Cap

488.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRTA
KMDA
Founded
2014
1990
Country
United States
Israel
Employees
601
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
425.3M
488.6M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
SRTA
KMDA
Price
$5.53
$8.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$7.81
$14.00
AVG Volume (30 Days)
741.8K
33.9K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
3.08%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$39.27
$13.94
Revenue Next Year
$8.52
$9.84
P/E Ratio
$9.88
$24.59
Revenue Growth
N/A
N/A
52 Week Low
$3.85
$6.50
52 Week High
$6.02
$9.35

Technical Indicators

Market Signals
Indicator
SRTA
KMDA
Relative Strength Index (RSI) 69.70 57.92
Support Level $4.08 $8.38
Resistance Level $5.99 $8.60
Average True Range (ATR) 0.30 0.18
MACD 0.06 0.03
Stochastic Oscillator 93.89 96.74

Price Performance

Historical Comparison
SRTA
KMDA

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: